Additional contributors to the increased genetic risk of APOE4 in AD may include impaired Aβ clearance, exacerbated oxidative stress and neuroinflammation (reviewed in [21–23]), and loss of critical apoE functions. Here, APOE is linked to Alzheimer disease.